2017 Drug Discovery and Therapy World Congress
July 10, 2017 ·
Events and Presentations
All Categories
- All Categories
- Kevetrin
- Corporate
- Corporate
- Prurisol
- Corporate
- Brilacidin
- Brilacidin
- Corporate
- Corporate
- Brilacidin
- Kevetrin
- Brilacidin
- Brilacidin
- Brilacidin
- Brilacidin
- Brilacidin
- Kevetrin
- Brilacidin
- Brilacidin
- Brilacidin
- Kevetrin
- Kevetrin
- Kevetrin
- Kevetrin
- Kevetrin
- Kevetrin
- Kevetrin
- Kevetrin
- Kevetrin
- Kevetrin
UpComing EVENTS
Archived Events
2017 American Association for Cancer Research (AACR) Annual Meeting
April 4, 2017 ·
9th Annual 2017 Biotech Showcase
January 9, 2017 ·
Q1 Fiscal 2017 Update
November 15, 2016 ·
14th Annual Discovery on Target Conference: “Prurisol: A New Small Molecule Under Investigation for the Treatment of Psoriasis”
September 19, 2016 ·
23rd Annual Newsmakers in the Biotech Industry Conference: “Corporate Overview”
September 9, 2016 ·
American Society for Microbiology Microbe 2016: “Application of Phamacokinetic-Pharmacodynamic Models for Brilacidin Dose Selection Support for Patients with Acute Bacterial Skin and Skin...
June 16, 2016 ·
American Society for Microbiology Microbe 2016: “Antifungal Potential of Peptide Mimetics in a Mouse Model of Invasive Candidiasis”
June 16, 2016 ·
LD Micro Corporate Presentation
June 7, 2016 ·
Biotech Showcase Corporate Presentation
January 11, 2016 ·
Joint 55th Interscience Conference on Antimicrobial Agents & Chemotherapy and 28th International Congress of Chemotherapy (ICAAC): “Population Pharmacokinetics (PPK) of Brilacidin in...
September 18, 2015 ·
American Society of Clinical Oncology (ASCO) Annual Meeting: “A Phase 1, Dose-Escalation, Safety, Pharmacokinetic, Pharmacodynamic Study of Thioureidobutyronitrile, a Novel p53...
May 30, 2015 ·
Understanding QIDP and Other 21st Century Incentives for Developing and Marketing Anti-Infectives: “A New Class of Antimicrobials—The HDP Mimetics”
May 21, 2015 ·
25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015): “A Randomized, Double-Blind Study Comparing Single-Dose and Short-Course Brilacidin...
April 27, 2015 ·
25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015): “Brilacidin, Host Defense Peptide Mimetic, One of a New Class of Immunomodulatory...
April 26, 2015 ·
25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2015): “Synthetic Novel Host Defense Protein Mimetics for the Treatment of Gram-Negative Bacterial Infections”
April 26, 2015 ·
2013 Elsevier Therapeutic Area Partnership (TAP): “Infectious Diseases: Top Projects to Watch”
November 19, 2013 ·
American Society of Clinical Oncology (ASCO) Annual Meeting: “A Phase 1, Dose-Escalation, Safety, Pharmacokinetic, Pharmacodynamic Study of Thioureidobutyronitrile, a Novel p53...
June 3, 2013 ·
23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2013): “Use of Pharmacokinetics-Pharmacodynamics and Monte Carlo Simulation Analyses to Support Brilacidin...
April 19, 2013 ·
23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2013): “Population Pharmacokinetic Analyses of Brilacidin Using Data from Patients with ABSSSI”
April 19, 2013 ·